In 2017,Bayliss, Tracy; Robinson, David A.; Smith, Victoria C.; Brand, Stephen; McElroy, Stuart P.; Torrie, Leah S.; Mpamhanga, Chido; Norval, Suzanne; Stojanovski, Laste; Brenk, Ruth; Frearson, Julie A.; Read, Kevin D.; Gilbert, Ian H.; Wyatt, Paul G. published 《Design and Synthesis of Brain Penetrant Trypanocidal N-Myristoyltransferase Inhibitors》.Journal of Medicinal Chemistry published the findings.Electric Literature of C7H9NO The information in the text is summarized as follows:
N-Myristoyltransferase (NMT) represents a promising drug target within the parasitic protozoa Trypanosoma brucei (T. brucei), the causative agent for human African trypanosomiasis (HAT) or sleeping sickness. The authors have previously validated T. brucei NMT as a promising druggable target for the treatment of HAT in both stages 1 and 2 of the disease. The authors report on the use of the previously reported DDD85646 as a starting point for the design of a class of potent, brain penetrant inhibitors of T. brucei NMT. After reading the article, we found that the author used 2-(2-Hydroxyethyl)pyridine(cas: 103-74-2Electric Literature of C7H9NO)
2-(2-Hydroxyethyl)pyridine(cas: 103-74-2) belongs to pyridine. Pyridine is very deactivated towards electrophilic substitution with respect to benzene. For this reason classical formylation, using methods such as the Gattermann or Vilsmeier reactions, are not generally successful. Electric Literature of C7H9NO